Literature DB >> 35108118

The importance of mitochondrial quality control for maintaining skeletal muscle function across health span.

James Sligar1,2, Danielle A DeBruin3,4, Nicholas J Saner5, Ashleigh M Philp1,2, Andrew Philp1,2.   

Abstract

As the principal energy-producing organelles of the cell, mitochondria support numerous biological processes related to metabolism, growth, and regeneration in skeletal muscle. Deterioration in skeletal muscle functional capacity with age is thought to be driven in part by a reduction in skeletal muscle oxidative capacity and reduced fatigue resistance. Underlying this maladaptive response is the development of mitochondrial dysfunction caused by alterations in mitochondrial quality control (MQC), a term encompassing processes of mitochondrial synthesis (biogenesis), remodeling (dynamics), and degradation (mitophagy). Knowledge regarding the role and regulation of MQC in skeletal muscle and the influence of aging in this process has rapidly advanced in the past decade. Given the emerging link between aging and MQC, therapeutic approaches to manipulate MQC to prevent mitochondrial dysfunction during aging hold tremendous therapeutic potential.

Entities:  

Keywords:  aging; metabolism; mitochondria; sarcopenia; skeletal muscle

Mesh:

Year:  2022        PMID: 35108118     DOI: 10.1152/ajpcell.00388.2021

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  2 in total

Review 1.  Mechanisms of Estrogen Influence on Skeletal Muscle: Mass, Regeneration, and Mitochondrial Function.

Authors:  Andrea Pellegrino; Peter M Tiidus; Rene Vandenboom
Journal:  Sports Med       Date:  2022-07-30       Impact factor: 11.928

2.  Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis.

Authors:  Lanqi Li; Donghong Cai; Huiya Zhong; Fengbin Liu; Qilong Jiang; Jian Liang; Peiwu Li; Yafang Song; Aidong Ji; Wei Jiao; Jingwei Song; Jinqiu Li; Zhiwei Chen; Qing Li; Lingling Ke
Journal:  Exp Ther Med       Date:  2022-02-24       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.